NIH Launches $1.5B Rapid COVID-19 Testing Technology Challenge

Share on Social Media

A new initiative announced by the National Institutes of Health (HNIH), backed by a $1.5 billion investment from federal stimulus funding, aims to speed innovation, development, and commercialization of COVID-19 testing technologies. Dubbed the Rapid Acceleration of Diagnostics (RADx) initiative the new program will infuse funding into early innovative technologies to speed development of rapid and widely accessible COVID-19 testing.

Read Full Article »

Latest News

ProThera Biologics Awarded $2-Million Fast Track NIH Grant

ProThera Biologics Awarded $2-Million Fast Track NIH Grant Company is Developing an Important Biomarker to Assess Outcomes in Neonates with Sepsis or Necrotizing Enterocolitis (NEC) in Support of Its Therapeutic  Development Programs Providence, R.I., June 19, 2019 –...

Biotech Industry News